ALBUMIN HUMAN

Search structure
Trade Names:
Synonyms:
Status: Approved (1997)
Entry Type: Protein
Molecule Category: UNKNOWN
UNII: ZIF514RVZR

Pharmacology

Action Mechanism of Action Reference
SEQUESTERING AGENT Bilirubin sequestering agent

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Liver Cirrhosis 3 D008103 ClinicalTrials
Abortion, Habitual 3 D000026 ClinicalTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 3 D020277 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 3 D029424 ClinicalTrials
Shock, Septic 3 D012772 ClinicalTrials
Edema 3 D004487 ClinicalTrials
Sepsis 3 D018805 ClinicalTrials
Pancreatic Neoplasms 3 D010190 ClinicalTrials
Ascites 3 D001201 ClinicalTrials
Ischemic Stroke 3 D000083242 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Alzheimer Disease 3 D000544 ClinicalTrials
Pancreatic Neoplasms 3 D010190 ClinicalTrials
Orthostatic Intolerance 3 D054971 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 3 D000077195 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Paraganglioma 3 D010235 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Endometrial Neoplasms 3 D016889 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Scleroderma, Systemic 2 D012595 ClinicalTrials
Adenocarcinoma 2 D000230 ClinicalTrials
Kidney Diseases 2 D007674 ClinicalTrials
Shock 2 D012769 ClinicalTrials
Cerebral Infarction 2 D002544 ClinicalTrials
Graft vs Host Disease 2 D006086 ClinicalTrials
alpha 1-Antitrypsin Deficiency 2 D019896 ClinicalTrials
Cerebral Hemorrhage 2 D002543 ClinicalTrials
Inflammation 2 D007249 ClinicalTrials
Burns 2 D002056 ClinicalTrials
Pneumonia 2 D011014 ClinicalTrials
Multiple Sclerosis, Relapsing-Remitting 2 D020529 ClinicalTrials
Adrenoleukodystrophy 2 D000326 ClinicalTrials
Amyotrophic Lateral Sclerosis 2 D000690 ClinicalTrials
Adrenoleukodystrophy 2 D000326 ClinicalTrials
Adenocarcinoma of Lung 2 D000077192 ClinicalTrials
Craniocerebral Trauma 2 D006259 ClinicalTrials
Macular Degeneration 2 D008268 ClinicalTrials
Subarachnoid Hemorrhage 1 D013345 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Central Nervous System Neoplasms 1 D016543 ClinicalTrials
Heart Failure, Systolic 1 D054143 ClinicalTrials
Sarcoma 1 D012509 ClinicalTrials
Hypotension, Orthostatic 1 D007024 ClinicalTrials

Side Effects from Label

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
20.69
Nervous system disorders
12.26
Cardiac disorders
10.73
Gastrointestinal disorders
9.96
Respiratory, thoracic and mediastinal disorders
8.81
Vascular disorders
8.05
Injury, poisoning and procedural complications
6.9
Investigations
4.6
Musculoskeletal and connective tissue disorders
4.6
Immune system disorders
4.21
Psychiatric disorders
3.07
Product issues
3.07

Cross References

Resources Reference
CAS NUMBER 9048-46-8
ChEMBL CHEMBL1201451
FDA SRS ZIF514RVZR
CONTENTS